Literature DB >> 12121150

Inhibition of telomerase by linear-chain fatty acids: a structural analysis.

Masako Oda1, Takamasa Ueno, Nobuyuki Kasai, Hirotada Takahashi, Hiromi Yoshida, Fumio Sugawara, Kengo Sakaguchi, Hideya Hayashi, Yoshiyuki Mizushina.   

Abstract

In the present study, we have found that mono-unsaturated linear-chain fatty acids in the cis configuration with C(18) hydrocarbon chains (i.e. oleic acid) strongly inhibited the activity of human telomerase in a cell-free enzymic assay, with an IC(50) value of 8.6 microM. Interestingly, fatty acids with hydrocarbon chain lengths below 16 or above 20 carbons substantially decreased the potency of inhibition of telomerase. Moreover, the cis-mono-unsaturated C(18) linear-chain fatty acid oleic acid was the strongest inhibitor of all the fatty acids tested. A kinetic study revealed that oleic acid competitively inhibited the activity of telomerase ( K (i)=3.06 microM) with respect to the telomerase substrate primer. The energy-minimized three-dimensional structure of the linear-chain fatty acid was calculated and modelled. A molecule width of 11.53-14.26 A (where 1 A=0.1 nm) in the C(16) to C(20) fatty acid structure was suggested to be important for telomerase inhibition. The three-dimensional structure of the telomerase active site (i.e. the substrate primer-binding site) appears to have a pocket that could bind oleic acid, with the pocket being 8.50 A long and 12.80 A wide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121150      PMCID: PMC1222903          DOI: 10.1042/BJ20021089

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.

Authors:  T Ueno; H Takahashi; M Oda; M Mizunuma; A Yokoyama; Y Goto; Y Mizushina; K Sakaguchi; H Hayashi
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

3.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.

Authors:  J L Mergny; L Lacroix; M P Teulade-Fichou; C Hounsou; L Guittat; M Hoarau; P B Arimondo; J P Vigneron; J M Lehn; J F Riou; T Garestier; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Synthesis of sulfoquinovosylacylglycerols, inhibitors of eukaryotic DNA polymerase alpha and beta.

Authors:  S Hanashima; Y Mizushina; T Yamazaki; K Ohta; S Takahashi; H Sahara; K Sakaguchi; F Sugawar
Journal:  Bioorg Med Chem       Date:  2001-02       Impact factor: 3.641

5.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes.

Authors:  F Koeppel; J F Riou; A Laoui; P Mailliet; P B Arimondo; D Labit; O Petitgenet; C Hélène; J L Mergny
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

7.  Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.

Authors:  I Naasani; H Seimiya; T Tsuruo
Journal:  Biochem Biophys Res Commun       Date:  1998-08-19       Impact factor: 3.575

8.  9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.

Authors:  N Sato; K Mizumoto; M Kusumoto; H Niiyama; N Maehara; T Ogawa; M Tanaka
Journal:  FEBS Lett       Date:  1998-12-18       Impact factor: 4.124

9.  Inhibition of human telomerase by 2'-O-methyl-RNA.

Authors:  A E Pitts; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Structure-activity relationship of a novel group of mammalian DNA polymerase inhibitors, synthetic sulfoquinovosylacylglycerols.

Authors:  S Hanashima; Y Mizushina; K Ohta; T Yamazaki; F Sugawara; K Sakaguchi
Journal:  Jpn J Cancer Res       Date:  2000-10
View more
  4 in total

1.  Structural insight into the differential effects of omega-3 and omega-6 fatty acids on the production of Abeta peptides and amyloid plaques.

Authors:  Zareen Amtul; Markus Uhrig; Richard F Rozmahel; Konrad Beyreuther
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

2.  Suppression of superoxide anion and elastase release by C18 unsaturated fatty acids in human neutrophils.

Authors:  Tsong-Long Hwang; Yi-Chia Su; Han-Lin Chang; Yann-Lii Leu; Pei-Jen Chung; Liang-Mou Kuo; Yi-Ju Chang
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

3.  Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases.

Authors:  Yoshiyuki Mizushina; Jinhui Zhang; Angelo Pugliese; Sung-Hoon Kim; Junxuan Lü
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 6.100

4.  3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain.

Authors:  Yoshiyuki Mizushina; Hirohisa Motoshima; Yasuhiro Yamaguchi; Toshifumi Takeuchi; Ken Hirano; Fumio Sugawara; Hiromi Yoshida
Journal:  Mar Drugs       Date:  2009-11-23       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.